KISSINGER THOMAS F 4

4 · MARCUS CORP · Filed Feb 13, 2026

AI-generated summary of this filing

Updated Feb 13, 2026

Marcus Corp (MCS) Thomas Kissinger Receives Restricted Stock Award

What Happened

Thomas F. Kissinger, Senior Executive Vice President, General Counsel & Secretary and a company director at Marcus Corp (MCS), received a grant of 31,990 restricted common shares on February 11, 2026. The grant is reported at $0.00 per share (total reported value $0), reflecting an awarded equity grant rather than an open‑market purchase.

Key Details

Transaction type: Award/Grant (code A)
Transaction date: February 11, 2026; Form 4 filed February 13, 2026 (filed two days after the grant)
Shares granted: 31,990 restricted shares; price reported: $0.00
Shares owned after transaction: not specified in the filing
Relevant footnote: F1 — the restricted stock vests 50% after the 2nd anniversary of the grant and 100% after the 3rd anniversary
Other footnotes in the filing (F2–F5) relate to separate plans/vesting schedules and broader holdings disclosure, not this specific grant

Context

This was an equity award, not a cash purchase or sale. Restricted stock grants typically vest over time (here, a two‑ to three‑year schedule), so the shares are not immediately transferable until vesting conditions are met. Such grants compensate or retain executives and do not by themselves indicate immediate buying or selling sentiment.

Form 4

Period: 2026-02-11

DirectorSr Exec VP, Gen Counsel & Secy

Transactions

Holdings

Common Stock
[F2]
(indirect: By Plan)
547
Common Stock
[F3]
(indirect: By 401(k))
1,581
Stock Option (right to buy) (granted 2/28/17)
[F4]
Exercise: $31.20Exp: 2027-02-28→ Common Stock (17,000 underlying)
17,000
Stock Option (right to buy) (granted 2/27/18)
[F4]
Exercise: $27.00Exp: 2028-02-27→ Common Stock (24,400 underlying)
24,400
Stock Option (right to buy) (granted 2/26/19)
[F4]
Exercise: $41.90Exp: 2029-02-26→ Common Stock (23,400 underlying)
23,400
Stock Option (right to buy) (granted 2/25/20)
[F4]
Exercise: $28.88Exp: 2030-02-25→ Common Stock (39,000 underlying)
39,000
Stock Option (right to buy) (granted 3/9/21)
[F4]
Exercise: $21.84Exp: 2031-03-09→ Common Stock (47,100 underlying)
47,100
Stock Option (right to buy) (granted 3/8/22)
[F5]
Exercise: $17.04Exp: 2032-03-08→ Common Stock (50,000 underlying)
50,000
Stock Option (right to buy) (granted 3/7/23)
[F5]
Exercise: $15.99Exp: 2033-03-07→ Common Stock (56,600 underlying)
56,600

Footnotes (5)

[F1]Restricted stock granted February 11, 2026 vests and becomes exercisable as follows: 50% after 2nd anniversary of date of grant and 100% after 3rd anniversary of date of grant.
[F2]By Dividend Reinvestment and Associate Stock Purchase Plan
[F3]Balance reflects the most current data available with regard to the reporting person's holdings in the 401(k) Plan.
[F4]The options originally granted vest and become exercisable as follows: 40% after 2nd anniversary of the date of grant; 60% after 3rd anniversary; 80% after 4th anniversary; and 100% after 5 years.
[F5]The options originally granted vest and become exercisable as follows: 50% after 2nd anniversary of the date of grant; 75% after 3rd anniversary; and 100% after 4 years.

Signature

/s/ Steven R. Barth, Attorney-in-Fact for Thomas F. Kissinger|2026-02-13

1 file